Medline Inc. (MDLN)
NASDAQ
Closed
Aug 24, 2026
Day's Range
34.2352 wk Range
32.48Overview - MDLN - Medline Inc.
Key Statistics
Valuation
Enterprise Value
47.50B
P/E (Trailing)
‪42.82‬
P/E (Forward)
‪21.77‬
PEG Ratio
‪-0.51‬
Price / Sales (TTM)
‪1.53‬
Price / Book
‪2.59‬
EV / EBITDA
‪18.86‬
Profitability
Gross Margin
‪28.82%‬
Profit Margin
‪2.31%‬
Operating Margin
‪0.82%‬
Return on Assets
‪2.46%‬
Return on Equity
‪4.93%‬
Ownership
Shares Outstanding
877.00M
Float
341.00M
Short % of Shares Outstanding
‪8.21%‬
Held by Insiders
‪0.25%‬
Held by Institutions
‪115.33%‬
Price stats
50-Day Avg
‪37.99‬
200-Day Avg
‪41.36‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
27 analysts
Average price target
‪$ 44.62‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MDLN - Medline Inc.
Peers - MDLN - Medline Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NASDAQ.
Profile Summary - MDLN - Medline Inc.
About
Medline Inc. is a healthcare company that provides medical-surgical products and supply chain solutions to healthcare providers. The company focuses on serving hospitals, surgery centers, physician offices, laboratories, and post-acute care facilities with a broad portfolio of consumable medical products, including…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
